Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Reaches a New Pinnacle

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stock has seen a rise as of late. Shares have hit a new 52-week high after reaching $18.66 during recent trading action. Investors will be watching to see if the name can maintain momentum heading into the new year.Since the start of the calendar year, Collegium Pharmaceutical, Inc. (NASDAQ:COLL)’s stock has changed 8.80%. Over the last five trading sessions, the stock has moved 9.15%. For the past month, Collegium Pharmaceutical, Inc.’s stock has been 82.15%, 71.98% for the last quarter, 64.47% for the past six months and 0.95% for the past 52 weeks.

Based on current stock levels, Collegium Pharmaceutical, Inc. shares are trading -2.85% off of the 50-day high and 107.13% away from the 50-day low.

Earnings Per Share (EPS), the portion of a company’s profit distributed to each outstanding common share, is a useful indicator of a company’s profitability. EPS is typically considered to be the most important variable in determining a share’s price. Collegium Pharmaceutical, Inc. (NASDAQ:COLL)’s EPS growth this year is -1.40% and the trailing 12-month EPS is $-2.97. Covering sell-side analysts are estimating company growth for next year to be 40.50%. On a consensus basis, analysts have given a recommendation of 1.60 on company shares.

Leave a Comment